Repligen Corporation to Present at Wells Fargo 21st Annual Healthcare Conference
WALTHAM, Mass., Aug. 26, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will participate in the Wells Fargo 21st Annual Healthcare Conference in Boston, MA. Olivier Loeillot, President and Chief Executive Officer and Jason Garland, Chief Financial Officer, will participate in an analyst-led discussion on September 9th at 1:30 p.m. ET.
Covered in this story
What has happened since
- Wells Fargo is down 4.2% since this was published, 40 days ago.
Price move measured from the close nearest publication to the latest quote.
Analyst targets on Wells Fargo
- Morgan Stanley: $80.5 → $102 by Oct 2027 · Overweight via Investing.com India
- JPMorgan: $80.5 → $91.5 by Oct 2027 · Neutral via GuruFocus
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $WFC yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Wells Fargo →Dalsna Finance is currently tracking 59 stories mentioning Wells Fargo, the earliest published 27 May 2026.
Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.